Glenmark Pharmaceuticals Inc., USA recalls
19 recall notices naming Glenmark Pharmaceuticals Inc., USA since January 2025, in United States. The most recent was published 4 Nov 2026.
Latest recalls (19)
- Glenmark Pharmaceuticals Inc., USA recalls Abiraterone Acetate Tablets USP 500 mgFDALabeling: Not Elsewhere Classified
- Glenmark Pharmaceuticals Inc., USA recalls Azelaic Acid GelFDACGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.
- Glenmark Pharmaceuticals Inc., USA recalls Alyacen 7/7/7FDAFailed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
- Glenmark Pharmaceuticals Inc., USA recalls Ondansetron Orally Disintegrating TabletsFDADefective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and…
- Glenmark Pharmaceuticals Inc., USA recalls Nebivolol TabletsFDACross Contamination with Other Products
- Glenmark Pharmaceuticals Inc., USA recalls Bisoprolol Fumarate and Hydrochlorothiazide TabletsFDACross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe
- Glenmark Pharmaceuticals Inc., USA recalls VioreleFDAFailed Impurities/Degradation Specifications
- Glenmark Pharmaceuticals Inc., USA recalls Azelaic Acid GelFDACGMP Deviations: Market complaints received for gritty texture (grainy)
- Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsFDACGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.
- Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsFDACGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
- Glenmark Pharmaceuticals Inc., USA recalls Theophylline extended-release tablets 400mgFDAFailed Dissolution Specifications: Failure results (above) were reported for the Dissolution (by UV) test for commercial annual stability at the…
- Glenmark Pharmaceuticals Inc., USA recalls Ezetimibe and Simvastatin TabletsFDAFailed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time…
- Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets USP 25 mg and 3 moreFDACGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
- Glenmark Pharmaceuticals Inc., USA recalls Theophylline (Anhydrous) Extended-Release TabletsFDAOOS results reported for the Dissolution (by UV) test.
- Glenmark Pharmaceuticals Inc., USA recalls Cetirizine Hydrochloride Tablets and 35 moreFDACGMP Deviations
- Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride TabletsFDACGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.
- Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesFDACGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
- Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsFDACGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.
- Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride TabletsFDACGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.